ReviewCureus2025

Comparative Risk Assessment in Hypertensive Patients With Metabolic Syndrome by Exploring Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers.

Muhammad Haris Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.